Funding news for global health researchers: December 5, 2022
On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding
opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates
are typically distributed once a week.
Upcoming Deadlines for Fogarty Funding Opportunities
Upcoming deadlines for funding opportunities in which Fogarty is a funding partner:
Funding Opportunities
NIH funding opportunities focusing on global health and foreign collaboration:
NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply:
-
Designing and Performing a Virtual Bioequivalence Trial for Physiologically-Based Pharmacokinetic and other Mechanism-Based Models (U01) Clinical Trial Not Allowed (RFA-FD-23-016)
Application receipt date(s): February 15, 2023 -
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional (RFA-FD-23-008)
Application receipt date(s): February 27, 2023 -
Population Pharmacokinetic Modeling of Systemic Pharmacokinetic Data to Inform Bioequivalence in Regional Lung Exposure (U01) Clinical Trial Not Allowed (RFA-FD-23-017)
Application receipt date(s): February 28, 2023 -
Evaluation of Oral Modified Release Dosage Forms to Support the Approval of Additional Strengths (U01) Clinical Trial Not Allowed (RFA-FD-23-008)
Application receipt date(s): March 15, 2023 -
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (RFA-CA-23-002)
Application receipt date(s): Multiple dates, see announcement. -
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (RFA-CA-23-003)
Application receipt date(s): Multiple dates, see announcement. -
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (RFA-CA-23-004)
Application receipt date(s): Multiple dates, see announcement. -
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (RFA-CA-23-005)
Application receipt date(s): Multiple dates, see announcement. - Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research funding opportunities:
-
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) (PAR-23-036)
Application receipt date(s): Multiple dates, see announcement. -
Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional) (PAR-23-037)
Application receipt date(s): Multiple dates, see announcement. -
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) (PAR-23-057)
Application receipt date(s): Multiple dates, see announcement. -
Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed) (RFA-DK-22-027)
Application receipt date(s): Multiple dates, see announcement.
NIH funding opportunities for which foreign components may apply:
Funding opportunities in which NIH is a funding partner with an outside institution(s):
Other Funding News
Other funding updates that may be of interest to global health researchers.
General NIH notices:
Notice of changes to NIH funding opportunities:
- Early Expiration notices:
NIH Notices of Special Interest (NOSIs):
Non-NIH funding opportunities:
-
Cooley’s Anemia Foundation is accepting applications for grants supporting ongoing clinical research projects in thalassemia and fellowships in thalassemia research.
Application deadline: December 20, 2022 -
The Takemi Program in International Health at the Harvard T.H. Chan School of Public Health is accepting applications from mid-career professionals for fellowships focusing on mobilizing, allocating, and maintaining limited resources to improve health.
Application deadline: December 31, 2022 - The Union for International Cancer Control (UICC) is accepting applications for two programs
Application deadline: December 31, 2022
-
Grand Challenges Africa seeks innovative approaches to enhance climate adaptation for agriculture in Africa in ways that link directly with and strengthen the ecosystem of local actors and institutions.
Application deadline: January 15, 2023 -
Global Health Medical Student Research Fellowship offers medical students funding and support to dedicate one year to global health research.
Application deadline: January 16, 2023 - USAID is seeking applications to implement the
HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA) Project to support sub-Saharan African scientists, institutions, and innovative systems of collaboration in designing and testing improved HIV vaccine candidates.
Application deadline: March 28, 2023 -
More non-NIH funding opportunities
Training Opportunities
Abstract Submission Opportunities
Calls for Nominations
-
The Rachel Pearline Award recognizes one outstanding professional who embodies virtue and eminence in cancer research, practice, and/or training in a low- or middle-income country (LMIC) setting. Awardee will be recognized at the 11th Annual Symposium on Global Cancer Research on April 6, 2023.
Nomination deadline: December 30, 2022
Events
Events for global health researchers: